GlassScriptPhysician profile
Raymond Staniunas
NPI 1932169547
$4,093.62
in general payments reported to CMS, 2019-2025
19 companies · $514 in 2025
The $514 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $953 · 2020: $670 · 2021: $1,009 · 2022: $505 · 2023: $168 · 2024: $274 · 2025: $514.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $946 · Travel and Lodging: $10.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $945.99 |
| Travel and Lodging | $10.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conmed Corporation | $800.00 | 2019 | |
| Medtronic, INC. | $796.01 | 2021-2025 | Signia, Interstim |
| Stryker Corporation | $754.76 | 2021-2022 | |
| Intuitive Surgical, INC. | $640.03 | 2019-2021 | |
| Medtronic USA, INC. | $289.26 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $180.29 | 2024 | Gattex |
| Acera Surgical, INC. | $156.38 | 2021-2025 | Restrata Wound Matrix |
| Biotissue Holdings INC. | $118.37 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $66.34 | 2024-2025 | Exparel |
| Ethicon US, LLC | $64.20 | 2022 | |
| Mimedx Group, INC. | $52.75 | 2025 | |
| Kerecis Limited | $40.90 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Convatec INC. | $23.56 | 2025 | |
| Tela Bio, INC. | $23.07 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Boston Scientific Corporation | $22.01 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thd America, INC. | $19.64 | 2024 | |
| Kci USA, INC. | $18.34 | 2021 | |
| Covidien LP | $16.26 | 2019 | |
| Edwards Lifesciences Corporation | $11.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Staniunas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.